FDA approves first targeted therapy to treat a rare mutation in patients with gastrointestinal… EP News Bureau Jan 10, 2020 Ayvakit is a kinase inhibitor, meaning it blocks a type of enzyme called a kinase and helps keep the cancer cells from growing
